Immune Checkpoint Inhibitors in Triple Negative Breast Cancer Treatment: Promising Future Prospects
<div><p>Immunotherapy has emerged as the fifth pillar of cancer treatment alongside surgery, radiotherapy, chemotherapy, and targeted therapy. Immune checkpoint inhibitors are the current superheroes of immunotherapy, unleashing a patient’s own immune cells to kill tumors and revolutioni...
Saved in:
| Main Author: | Remy Thomas (702843) (author) |
|---|---|
| Other Authors: | Ghaneya Al-Khadairi (14153274) (author), Julie Decock (44558) (author) |
| Published: |
2021
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Editorial: Dynamic Biomarkers of Response to Anti-Immune Checkpoint Inhibitors in Cancer
by: Said Dermime (79420)
Published: (2021) -
Dynamic Biomarkers of Response to Anti-Immune Checkpoint Inhibitors in Cancer
by: Said Dermime (79420)
Published: (2021) -
A community challenge to predict clinical outcomes after immune checkpoint blockade in non-small cell lung cancer
by: Mike Mason (18007491)
Published: (2024) -
Breast Cancer Cells and PD-1/PD-L1 Blockade Upregulate the Expression of PD-1, CTLA-4, TIM-3 and LAG-3 Immune Checkpoints in CD4+ T Cells
by: Reem Saleh (3513056)
Published: (2019) -
Breast Cancer Cells and PD-1/PD-L1 Blockade Upregulate the Expression of PD-1, CTLA-4, TIM-3 and LAG-3 Immune Checkpoints in CD4+ T Cells
by: Reem Saleh (3513056)
Published: (2019)